Dr. Szewczuk is Full Professor of Immunology and Medicine over 38 years at Queen’s University, Kingston, Ontario Canada. Dr. Szewczuk’s research has focused on the role of glycosylation in receptor activation with a particular focus of Toll-like, neurotrophin Trk, EGFR  and insulin receptors. A novel receptor-signalling platform was discovered, and its targeted translation in multistage tumorigenesis. He is now in the development of engineered drug delivery systems.